Clinical protocol
RTOG 0915 protocol — SBRT for peripheral stage I NSCLC
NRG Oncology / RTOG
DoseLab summary
NRG Oncology's protocol page for RTOG 0915, linking the protocol PDF. Read the trial's normal-tissue constraints and its conformity and dose-falloff requirements in the protocol document. Results are published separately as the RTOG 0915 trial report.
Why this is useful
Go here for a peripheral-tumor SBRT trial's own requirements — normal-tissue limits and plan-quality criteria for its single-fraction and four-fraction schedules — as written in the protocol.
Reference details
- Title
- RTOG 0915 protocol — SBRT for peripheral stage I NSCLC
- Authors / organization
- NRG Oncology / RTOG
- Publication / protocol
- Protocol document, RTOG 0915 (NCCTG N0927)
- Version
- Version dated 2014-03-06 (per the NRG protocol page)
- Year
- Pending verification
- DOI
- Pending verification
- Disease sites
- Lung
- Topics
- Dose Constraints, SBRT, Protocols, RTOG, NRG, Peripheral tumors
- Fractionation context
- SBRT, 1 and 4 fractions
- Last reviewed by DoseLab
- Pending verification